Study Identifies Why TB Vaccines Are Ineffective
Researchers at the Washington University School of Medicine in St. Louis have discovered the reason the BCG vaccine and investigational vaccine candidates are not more effective.
New Autoimmune Disease Treatments Could Cause Fewer Side Effects
Because many of the current treatments for autoimmune diseases leave patients at greater risk of developing other opportunistic illnesses, a research team at the University of Oxford in England has been using genetics to possibly minimize the side effects of treatment.
CMS Adopts Four Options to Comply with MACRA
In response to concerns by physicians and other clinicians about their readiness to comply with the Medicare Access and CHIP Reauthorization Act (MACRA), which began Jan. 1, the Centers for Medicare and Medicaid Services (CMS) has revised implementation requirements by adopting four options that will allow providers to choose the level and pace at which they comply.
HHS Selects Physician Groups for Cancer Care Initiative
The U.S. Department of Health andHuman Services has selected nearly 200 physician group practices and 17health insurance companies to participate in a care delivery model that supports and encourages higher quality and more coordinated cancer care.
FDA Approves First Human Trial of a Zika Vaccine
The U.S. Food and Drug Administration has approved the first human trial of an experimental Zika virus vaccine.
HHS Issues Final Rule to Overhaul Managed Medicaid
In the first overhaul of managed care in Medicaid and the Children’s Health Insurance Program, the Department of Health and Human Services issued a final rule in an effort to deliver better care, smarter spending and healthier people.
CMS Finalizes ACO Cost Target Changes
The Centers for Medicare and Medicaid Services finalized changes to how it evaluates whether Medicare accountable care organizations are saving money.
Study Finds Influenza Vaccine’s Effectiveness Can Be Improved
Research conducted at the University of Texas at Austin found that how the influenza (flu) vaccine produces antibodies to protect against disease could be used to improve the vaccine.
Phase II Trial Launched of AAT for the Prevention of Lung Transplant Rejection
Kamada has initiated a Phase II clinicaltrial with its proprietary Alpha-1Antitrypsin (AAT) for the prevention oflung transplant rejection.
Sandoz Launches Generic Version of Crestor
Sandoz announced the U.S. market introduction of rosuvastatin calcium tablets, a generic version of Crestor by AstraZenica Pharmaceuticals LP.
